Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eshcol Pharmaceutical Group is a Singapore-based pharmaceutical company specializing in the marketing, sales, and distribution of healthcare products across Southeast Asia. The company manages a diverse portfolio that includes generic drugs, specialty pharmaceuticals, medical devices, and nutritional supplements. Eshcol acts as a strategic partner for global manufacturers seeking to enter the ASEAN market, providing comprehensive regulatory affairs, logistics, and market access services. Their therapeutic focus spans oncology, cardiology, and infectious diseases, aiming to improve patient access to affordable and high-quality medical solutions. The group is led by experienced industry professionals and maintains a strong network of healthcare providers and retail pharmacies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eshcol Pharmaceutical Group.